Cargando…

The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?

BACKGROUND: The hypothetical concept of ‘macrocyclic cavity’ is largely employed as useful model to interpret the affinity of metal ions for the macrocyclic chelating ligand 2,2′,2′′,2′′′-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (H(4)DOTA). It Is hypothesized that a close ma...

Descripción completa

Detalles Bibliográficos
Autor principal: Duatti, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400501/
https://www.ncbi.nlm.nih.gov/pubmed/37535275
http://dx.doi.org/10.1186/s41181-023-00202-6
_version_ 1785084460375474176
author Duatti, Adriano
author_facet Duatti, Adriano
author_sort Duatti, Adriano
collection PubMed
description BACKGROUND: The hypothetical concept of ‘macrocyclic cavity’ is largely employed as useful model to interpret the affinity of metal ions for the macrocyclic chelating ligand 2,2′,2′′,2′′′-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (H(4)DOTA). It Is hypothesized that a close matching between the size of the macrocyclic cavity and that of the metallic ion is a key parameter to ensure the high-yield formation of stable coordination metal-DOTA complex. This approach has become popular in the design of radiopharmaceuticals containing radiometals and H(4)DOTA as chelating group. RESULTS: Based on X-ray structural data of metallic complexes formed by the ligand H(4)DOTA upon coordination with a variety of metals, an elementary argument based on Euclidean geometry is presented here that questions the existence of the hypothetical ‘macrocyclic cavity’ within the chelator macrocycle. The geometrical analysis was applied to the complex formed by a Ga(3+) ion coordinated to H(4)DOTA as model compound. CONCLUSIONS: Application of Euclidean geometry to calculate bond angles in the coordination complex of the ligand H(4)DOTA with the Ga(+3) ion, supposed to incorporate a hypothetical ‘macrocyclic cavity’, revealed that this conceptual entity has no physical reality and, therefore, cannot be considered a meaningful description of a stable structural arrangement for metallic radiopharmaceuticals.
format Online
Article
Text
id pubmed-10400501
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-104005012023-08-05 The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality? Duatti, Adriano EJNMMI Radiopharm Chem Research Article BACKGROUND: The hypothetical concept of ‘macrocyclic cavity’ is largely employed as useful model to interpret the affinity of metal ions for the macrocyclic chelating ligand 2,2′,2′′,2′′′-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid (H(4)DOTA). It Is hypothesized that a close matching between the size of the macrocyclic cavity and that of the metallic ion is a key parameter to ensure the high-yield formation of stable coordination metal-DOTA complex. This approach has become popular in the design of radiopharmaceuticals containing radiometals and H(4)DOTA as chelating group. RESULTS: Based on X-ray structural data of metallic complexes formed by the ligand H(4)DOTA upon coordination with a variety of metals, an elementary argument based on Euclidean geometry is presented here that questions the existence of the hypothetical ‘macrocyclic cavity’ within the chelator macrocycle. The geometrical analysis was applied to the complex formed by a Ga(3+) ion coordinated to H(4)DOTA as model compound. CONCLUSIONS: Application of Euclidean geometry to calculate bond angles in the coordination complex of the ligand H(4)DOTA with the Ga(+3) ion, supposed to incorporate a hypothetical ‘macrocyclic cavity’, revealed that this conceptual entity has no physical reality and, therefore, cannot be considered a meaningful description of a stable structural arrangement for metallic radiopharmaceuticals. Springer International Publishing 2023-08-03 /pmc/articles/PMC10400501/ /pubmed/37535275 http://dx.doi.org/10.1186/s41181-023-00202-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Duatti, Adriano
The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
title The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
title_full The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
title_fullStr The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
title_full_unstemmed The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
title_short The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
title_sort dota macrocyclic cavity in metallic radiopharmaceuticals: mythology or reality?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400501/
https://www.ncbi.nlm.nih.gov/pubmed/37535275
http://dx.doi.org/10.1186/s41181-023-00202-6
work_keys_str_mv AT duattiadriano thedotamacrocycliccavityinmetallicradiopharmaceuticalsmythologyorreality
AT duattiadriano dotamacrocycliccavityinmetallicradiopharmaceuticalsmythologyorreality